Study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection
A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications.
Source: Medical Xpress